UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Which multinational drugmaker grew most rapidly in H1?
Daiichi Sankyo Korea achieved the most substantive sales growth among multi...
by Nam Doo-hyun
|
2018-07-25 11:52
라인
Pfizer Korea stops recruitment procedure
Pfizer Korea is stirring controversy, as the company abruptly canceled its ...
by Lee Han-soo
|
2018-07-24 17:01
라인
Antidiabetic drug Zemiglo up, cancer drug Supect down in H1 sales
Locally developed new drugs showed mixed performances in prescriptions in t...
by So Jae-hyeon
|
2018-07-24 11:11
라인
Stock declines, negative rumors haunt biotech industry
The local biotech industry is struggling with negative rumors on leading fi...
by So Jae-hyeon
|
2018-07-23 16:39
라인
Il-yang gets 1-month suspension on quadrivalent flu vaccine
The government has suspended Il-yang Pharmaceutical’s manufacturing of Tera...
by Lee Hye-seon
|
2018-07-20 14:58
라인
Latecomer Lixiana’s chase after Eliquis gets faster
Daiichi Sankyo’s Lixiana, a latecomer in the non-vitamin K antagonist oral ...
by So Jae-hyeon
|
2018-07-20 12:01
라인
Bifido wins patent for microbiome-based treatment in US
Bifido said it has become the first domestic company to win a patent for a ...
by So Jae-hyeon
|
2018-07-19 15:42
라인
Xofigo combinations raise fracture risk
Combinations using Bayer Korea’s prostate cancer treatment Xofigo Inj. (ing...
by Lee Hye-seon
|
2018-07-19 13:59
라인
Joint R&D program to test Keytruda combo in breast cancer patients
The Korea Drug Development Fund (KDDF) and MSD Korea have selected Genexine...
by Marian Chu
|
2018-07-18 17:53
라인
Kolon Life Science inks deal to sell Invossa to China
Kolon Life Science said Wednesday it has signed a deal to sell 230 billion ...
by So Jae-hyeon
|
2018-07-18 16:46
라인
L&K Biomed gets FDA nod for sacroiliac joint disease implant system
L&K Biomed has received the U.S. Food and Drug Administration’s approval We...
by Marian Chu
|
2018-07-18 16:26
라인
SK Bioscience to expand vaccine production facility
SK Bioscience is pursuing its growth strategy by expanding its vaccine prod...
by Marian Chu
|
2018-07-18 16:13
라인
ViroMed secures DNA production plant in US
ViroMed said Wednesday it acquired a DNA production facility in San Diego, ...
by Marian Chu
|
2018-07-18 15:02
라인
Dong-A ST’s Jublia dominates athlete’s foot drugs
The sales of Dong-A ST’s Jublia, a toenail fungal treatment, has grown rapi...
by So Jae-hyeon
|
2018-07-18 11:50
라인
Novo Nordisk Korea gets nod for diabetes drug Fiasp
Novo Nordisk Korea got the Ministry of Food and Drug Safety’s approval for ...
by Marian Chu
|
2018-07-18 11:50
라인
‘Koreans increasingly seeking out hair loss treatment’
The number of Koreans in their 40s getting hair loss treatments is increasi...
by Marian Chu
|
2018-07-17 16:08
라인
YD Life Science to proceed with P2 trial for diabetic retinopathy treatment
YD Life Science said it got the U.S. Food and Drug Administration’s go-ahea...
by Lee Han-soo
|
2018-07-17 14:52
라인
30% of psoriasis patients take more than 5 years to find correct therapy
Psoriasis patients see an average of three doctors and try four types of tr...
by Marian Chu
|
2018-07-17 14:52
라인
Pharmbio launched CINV treatment
Pharmbio Korea said Tuesday that it has released a prefilled syringe versio...
by Lee Han-soo
|
2018-07-17 14:02
라인
Korean eye drops selling well overseas
Korean eye drops made by Huons, Sam Chun Dang Pharm, and Hanlim Pharm are i...
by So Jae-hyeon
|
2018-07-17 11:36
-
이전
71
72
73
74
75
76
77
78
79
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top